Alnylam Pharmaceuticals Research Services Obligation — Transaction price remained flat by 0.0% to $100.50M in Q1 2026 compared to the prior quarter.
alny_segment_research_services_obligation_transaction_price| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $200.70M | $200.70M | $200.68M | $200.68M | $215.60M | $215.68M | $215.68M | $205.68M | $305.68M | $305.70M | $100.50M | $100.50M | $100.50M | $100.50M |
| QoQ Change | — | +0.0% | -0.0% | +0.0% | +7.4% | +0.0% | +0.0% | -4.6% | +48.6% | +0.0% | -67.1% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +7.4% | +7.5% | +7.5% | -4.6% | +41.7% | — | — | — | — | — |